BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24556691)

  • 1. Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer.
    De Summa S; Pinto R; Pilato B; Sambiasi D; Porcelli L; Guida G; Mattioli E; Paradiso A; Merla G; Micale L; De Nittis P; Tommasi S
    Cell Death Dis; 2014 Feb; 5(2):e1076. PubMed ID: 24556691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of interaction of XRCC1 with DNA and proteins of base excision repair by photoaffinity labeling technique.
    Nazarkina ZhK; Khodyreva SN; Marsin S; Radicella JP; Lavrik OI
    Biochemistry (Mosc); 2007 Aug; 72(8):878-86. PubMed ID: 17922646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.
    Santos JC; Funck A; Silva-Fernandes IJ; Rabenhorst SH; Martinez CA; Ribeiro ML
    Int J Mol Sci; 2014 Sep; 15(10):17333-43. PubMed ID: 25268610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical significance of PARP1 protein expression in breast cancer.
    Green AR; Caracappa D; Benhasouna AA; Alshareeda A; Nolan CC; Macmillan RD; Madhusudan S; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2015 Jan; 149(2):353-62. PubMed ID: 25528020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype.
    Tommasi S; Pinto R; Danza K; Pilato B; Palumbo O; Micale L; De Summa S
    Oncotarget; 2016 Dec; 7(49):80363-80372. PubMed ID: 27385001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness.
    Darbeheshti F; Kadkhoda S; Keshavarz-Fathi M; Razi S; Bahramy A; Mansoori Y; Rezaei N
    BMC Cancer; 2022 Jun; 22(1):668. PubMed ID: 35715772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.
    Mengwasser KE; Adeyemi RO; Leng Y; Choi MY; Clairmont C; D'Andrea AD; Elledge SJ
    Mol Cell; 2019 Mar; 73(5):885-899.e6. PubMed ID: 30686591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
    Osorio A; Milne RL; Kuchenbaecker K; Vaclová T; Pita G; Alonso R; Peterlongo P; Blanco I; de la Hoya M; Duran M; Díez O; Ramón Y Cajal T; Konstantopoulou I; Martínez-Bouzas C; Andrés Conejero R; Soucy P; McGuffog L; Barrowdale D; Lee A; ; Arver B; Rantala J; Loman N; Ehrencrona H; Olopade OI; Beattie MS; Domchek SM; Nathanson K; Rebbeck TR; Arun BK; Karlan BY; Walsh C; Lester J; John EM; Whittemore AS; Daly MB; Southey M; Hopper J; Terry MB; Buys SS; Janavicius R; Dorfling CM; van Rensburg EJ; Steele L; Neuhausen SL; Ding YC; Hansen TV; Jønson L; Ejlertsen B; Gerdes AM; Infante M; Herráez B; Moreno LT; Weitzel JN; Herzog J; Weeman K; Manoukian S; Peissel B; Zaffaroni D; Scuvera G; Bonanni B; Mariette F; Volorio S; Viel A; Varesco L; Papi L; Ottini L; Tibiletti MG; Radice P; Yannoukakos D; Garber J; Ellis S; Frost D; Platte R; Fineberg E; Evans G; Lalloo F; Izatt L; Eeles R; Adlard J; Davidson R; Cole T; Eccles D; Cook J; Hodgson S; Brewer C; Tischkowitz M; Douglas F; Porteous M; Side L; Walker L; Morrison P; Donaldson A; Kennedy J; Foo C; Godwin AK; Schmutzler RK; Wappenschmidt B; Rhiem K; Engel C; Meindl A; Ditsch N; Arnold N; Plendl HJ; Niederacher D; Sutter C; Wang-Gohrke S; Steinemann D; Preisler-Adams S; Kast K; Varon-Mateeva R; Gehrig A; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S; Damiola F; Poppe B; Claes K; Piedmonte M; Tucker K; Backes F; Rodríguez G; Brewster W; Wakeley K; Rutherford T; Caldés T; Nevanlinna H; Aittomäki K; Rookus MA; van Os TA; van der Kolk L; de Lange JL; Meijers-Heijboer HE; van der Hout AH; van Asperen CJ; Gómez Garcia EB; Hoogerbrugge N; Collée JM; van Deurzen CH; van der Luijt RB; Devilee P; ; Olah E; Lázaro C; Teulé A; Menéndez M; Jakubowska A; Cybulski C; Gronwald J; Lubinski J; Durda K; Jaworska-Bieniek K; Johannsson OT; Maugard C; Montagna M; Tognazzo S; Teixeira MR; Healey S; ; Olswold C; Guidugli L; Lindor N; Slager S; Szabo CI; Vijai J; Robson M; Kauff N; Zhang L; Rau-Murthy R; Fink-Retter A; Singer CF; Rappaport C; Geschwantler Kaulich D; Pfeiler G; Tea MK; Berger A; Phelan CM; Greene MH; Mai PL; Lejbkowicz F; Andrulis I; Mulligan AM; Glendon G; Toland AE; Bojesen A; Pedersen IS; Sunde L; Thomassen M; Kruse TA; Jensen UB; Friedman E; Laitman Y; Shimon SP; Simard J; Easton DF; Offit K; Couch FJ; Chenevix-Trench G; Antoniou AC; Benitez J
    PLoS Genet; 2014 Apr; 10(4):e1004256. PubMed ID: 24698998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.
    Jacot W; Thezenas S; Senal R; Viglianti C; Laberenne AC; Lopez-Crapez E; Bibeau F; Bleuse JP; Romieu G; Lamy PJ
    BMC Cancer; 2013 Nov; 13():523. PubMed ID: 24191908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms of DNA base-excision repair genes (APE1, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population.
    Luo H; Li Z; Qing Y; Zhang SH; Peng Y; Li Q; Wang D
    Asian Pac J Cancer Prev; 2014; 15(3):1133-40. PubMed ID: 24606430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.
    Oplustilova L; Wolanin K; Mistrik M; Korinkova G; Simkova D; Bouchal J; Lenobel R; Bartkova J; Lau A; O'Connor MJ; Lukas J; Bartek J
    Cell Cycle; 2012 Oct; 11(20):3837-50. PubMed ID: 22983061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of the Poly(ADP-Ribose) Polymerase 1 Level on the Status of Base Excision Repair in Human Cells].
    Ilina ES; Kochetkova AS; Belousova EA; Kutuzov MM; Lavrik OI; Khodyreva SN
    Mol Biol (Mosk); 2023; 57(2):285-298. PubMed ID: 37000656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair.
    Demin AA; Hirota K; Tsuda M; Adamowicz M; Hailstone R; Brazina J; Gittens W; Kalasova I; Shao Z; Zha S; Sasanuma H; Hanzlikova H; Takeda S; Caldecott KW
    Mol Cell; 2021 Jul; 81(14):3018-3030.e5. PubMed ID: 34102106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
    Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI
    Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone.
    Chakrabarti G; Silvers MA; Ilcheva M; Liu Y; Moore ZR; Luo X; Gao J; Anderson G; Liu L; Sarode V; Gerber DE; Burma S; DeBerardinis RJ; Gerson SL; Boothman DA
    Sci Rep; 2015 Nov; 5():17066. PubMed ID: 26602448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA Gene Mutations and Poly(ADP-Ribose) Polymerase Inhibitors in Triple-Negative Breast Cancer.
    Okuma HS; Yonemori K
    Adv Exp Med Biol; 2017; 1026():271-286. PubMed ID: 29282689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected polymorphisms of base excision repair genes and pancreatic cancer risk in Japanese.
    Nakao M; Hosono S; Ito H; Watanabe M; Mizuno N; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H; Matsuo K
    J Epidemiol; 2012; 22(6):477-83. PubMed ID: 22850545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
    Kim KY; Han W; Noh DY; Kang D; Kwack K
    Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population.
    Li Y; Li S; Wu Z; Hu F; Zhu L; Zhao X; Cui B; Dong X; Tian S; Wang F; Zhao Y
    Med Oncol; 2013 Jun; 30(2):505. PubMed ID: 23430444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in base excision repair genes and thyroid cancer risk.
    Santos LS; Branco SC; Silva SN; Azevedo AP; Gil OM; Manita I; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2012 Nov; 28(5):1859-68. PubMed ID: 22922830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.